AGP Executive Report
Last update: 4 hours agoMedication Recall: Macleods Pharma USA, a New Jersey company, is recalling 3,744 bottles of a three-in-one blood pressure pill after tests found the tablets did not dissolve as expected. The recall covers two lots of olmesartan, amlodipine and hydrochlorothiazide; check the lot number with your pharmacist, and don’t stop treatment without medical advice. Cancer Research: A Rutgers-led team received a five-year, $6.5 million federal grant to advance lung cancer prevention, screening and survivorship care. Separately, RWJBarnabas Health and Rutgers Cancer Institute researchers contributed to a study supporting shorter radiation treatment for some breast cancer patients. Youth Mental Health: A new New Jersey clinic has opened to treat young patients battling mental illness. Community Health: New Jersey hospitals reported contributing $7.8 billion in community health benefits.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
